Inhibition of tumor growth in vitro by a combination of extracts from Rosa Roxburghii tratt and Fagopyrum Cymosum

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2409-2414

  Liu, Wei ^a   Li, Su Yi ^b   Huang, Xin En ^a   Cui, Jiu Jie ^b   Zhao, Ting ^b   Zhang, Hua ^b  

^a Department of Chemotherapy   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Apoptosis; Combination treatment; Fagopyrum cymosum; Proliferation; Rosa roxburghii Tratt; Tumor

Indexed keywords

BAX PROTEIN, HUMAN; MESSENGER RNA; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; ESOPHAGUS TUMOR; FAGOPYRUM; FLOW CYTOMETRY; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYTOTHERAPY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROSE; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FAGOPYRUM; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROSA; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84872682175     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2409     Document Type: Article

References (32)

1. Chen XF, Gu ZL, Liang ZQ (2001). Antitumor effect of the extract of Fagopyrum Cymosum. Suzhou Univ J Med Sci, 21, 23-5.
2. Chen XF, Gu ZL, Yang HH (2006). Induction of apoptosis and inhibition of telomerase activity by extract of Fagopyrum cymosum (Fr4) in human leukemia HL-60 cells. Chinese Pharmacological Bulletin, 22, 836-40.
3. Dai ZK, Yu LM, Yang XS (2005). Inhibitive effect of CL an extract of Rosa roxburghii Tratt on growth of gastric carcinoma cell lines in vitro. Guizhou Med J, 29, 786-9.
4. Gao LL, Huang XE, Zhang Q, et al (2011). A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial. Asian Pac J Cancer Prev, 12, 77-80.
5. Gong P, Huang XE, Chen CY, et al (2012). Comparison on Complications of Peripherally Inserted Central Catheters by Ultrasound Guide or Conventional Method in Cancer Patients. Asian Pac J Cancer Prev, (in press).
6. Huang XE, Li CG, Li Y, et al (2011). Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a phase II trial. Asian Pac J Cancer Prev, 12, 2797-800.
7. Hu WY, Bai Y, Han XF, et al (1994). Anti-atherosclerosis effect of Rosa roxburghii Tratt. Chin Pharm J, 29, 529-32.
8. Jemal A, Center MM, DeSantis C, et al (2010). Global Patterns of Incidence and Mortality Rates and Trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
9. Jiang Y, Huang XE, Yan PW, et al (2010). Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy. Asian Pacific J Cancer Prev, 11, 1059-62.
10. Li CG, Huang XE, Li Y, et al (2011). Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pac J Cancer Prev, 12, 487-90.
11. Li CG, Huang XE, Li Y, et al (2011). Clinical observations on safety and efficacy of OxyContin® administered by rectal route in treating cancer related pain. Asian Pac J Cancer Prev, 12, 477-8.
12. Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 301-4.
13. Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 12, 2405-9.
14. Matsumoto H, Wada T, Fukunaga K, et al (2004). Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. Jpn J Clin Oncol, 34, 124-30.
15. Parkin D M, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
16. Pui-Kwong C (2003). Inhibition of tumor growth in vitro by the extract of Fagopyrum cymosum (fago-c). Life Sciences, 72, 1851-8.
17. Qiang HJ, Zhang CN, Chen GY (2001). Effect of Roxburghii juice on the growth of human leukemia K562 cells. Chinese J Clin Oncol Rehabilitation, 7, 32-4.
18. Samel D, Donnella Deana A, De Witte P (1996). The effect of purified extract of Fagopyrum esculentum (Buckwheat) on protein kinases involved in signal transduction pathways. Planta Med, 62, 106-10.
19. Takeuchi H, Ozawa S, Ando N, et al (2003). Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol, 10, 792-800.
20. Wang J, Wei Q, Wang CY, et al (2004). Minocycline Up-regulates Bcl-2 and Protects against Cell Death in Mitochondria. J Biol Chem, 279, 19948-54.
21. Xu GP, Zhang CN, Wang JJ (2006). Inhibitory effect of RRTJ and NoniJ on the growth of human ovarian cancer cells. Chinese J Clin Labor Sci, 24, 137-9.
22. Xu HX, Huang XE, Li Y, et al (2011). A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer Prev, 12, 2233-6.
23. Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of Endostar® combined with chemotherapy in advanced colorectal cancer patients. Asian Pac J Cancer Prev, 12, 3087-90.
24. Xu JW, Li CG, Huang XE, 10. et al (2011). Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases. Asian Pac J Cancer Prev, 12, 985-7.
25. Yan PW, Huang XE, Jiang Y, et al (2010). A clinical comparison on safety and efficacy of Paclitaxel/Epirubicin (NE) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer. Asian Pac J Cancer Prev, 11, 1115-8.
26. Yan PW, Huang XE, Yan F, et al (2011). Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. Asian Pac J Cancer Prev, 12, 2291-4.
27. Yu DS, Huang XE, Zhou JN, et al (2012). A comparative studyon the value of anal preserving surgery for aged people with low rectal carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, (in press).
28. Zhang A, Long M, Jiang XY (1996). Anti-mutagenic effect of Cili juice enriched with SOD. Chin Pharm J, 31, 144-7.
29. Zhang LQ, Huang XE, Wang J (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5.
30. Zhang XZ, Huang XE, Xu YL, et al (2012). A phase II study on voriconazole in treating Chinese patients with malignant hematological disorder and invasive aspergillosis. Asian Pacific J Cancer Prev, (in press).
31. Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/Docetaxel combined with a paltinum in the treatment of advanced non-samll cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50.
32. Zhou L, Chang DC (2008). Dynamics and structure of the Bax-Bak complex responsible for releasing mitochondrial proteins during apoptosis. J Cell Sci, 121, 2186-96.